AR056695A1 - Tetrahidroquinolinas, su sintesis e intermediarios - Google Patents
Tetrahidroquinolinas, su sintesis e intermediariosInfo
- Publication number
- AR056695A1 AR056695A1 ARP060104498A ARP060104498A AR056695A1 AR 056695 A1 AR056695 A1 AR 056695A1 AR P060104498 A ARP060104498 A AR P060104498A AR P060104498 A ARP060104498 A AR P060104498A AR 056695 A1 AR056695 A1 AR 056695A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- compound
- independently
- perfluoroalkyl
- halogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/54—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of a saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
Reivindicacion 1: Un método para preparar un compuesto de formula (2) o una de sus sales aceptables para uso farmacéutico, donde: n es 0, 1 o 2; R1 y R2 son, cada uno en forma independiente, halogeno, -CN, fenilo, -R, -OR, -perfluoroalquilo C1-6 u - O-perfluoroalquilo C1-6; cada R es, en forma independiente, halogeno o un grupo alquilo C1-6 y R7 es -R, que comprende los pasos de: a) proporcionar un compuesto de formula (F) donde R1 y R2 son, cada uno en forma independiente, halogeno, -CN, fenilo, -R, -OR, -perfluoroalquilo C1-6 u -O-perfluoroalquilo C1-6; cada R es, en forma independiente, H o un grupo alquilo C1-6; PG1 es un grupo protector de aminos adecuado; y Ra es H o un grupo protector de carboxilos adecuado, b) hidrogenar dicho compuesto de formula (F) en forma asimétrica para dar un compuesto de formula (E) en una forma enriquecida en un enantiomero, donde: R1 y R2 son, cada uno en forma independiente, halogeno.-CN, fenilo, -R, -OR, -perfluoroalquilo C1-6 u -O- perfluoroalquilo C1-6; cada R es, en forma independiente, H o un grupo alquilo C1-6; PG1 es un grupo protector de aminos adecuado; y Ra es H o un grupo protector de carboxilos adecuado; c) desproteger y ciclar un compuesto de formula (E) para formar un compuesto de formula (D): donde R1 y R2 son, cada uno en forma independiente, halogeno.-CN, fenilo, -R, -OR, -perfluoroalquilo C1-6 u -O-perfluoroalquilo C1-6; y cada R es, en forma independiente, H o un grupo alquilo C1-6; d) tratar dicho compuesto de formula (D) con un agente reductor adecuado para formar un compuesto de formula (C): donde R1 y R2 son, cada uno en forma independiente, halogeno.-CN, fenilo, -R, -OR, -perfluoroalquilo C1-6 u -O-perfluoroalquilo C1-6; y cada R es, en forma independiente, H o un grupo alquilo C1-6; e) alquilar dicho compuesto de formula (C) para formar un compuesto de formula (B) donde n es 0, 1 o 2; R1 y R2 son, cada uno en forma independiente, halogeno.-CN, fenilo, -R, -OR, -perfluoroalquilo C1- 6 u -O-perfluoroalquilo C1-6; cada R es, en forma independiente, H o un grupo alquilo C1-6 y PG2 es un grupo protector de aminos adecuado; f) desproteger dicho compuesto de formula (B) para formar un compuesto de formula (A) donde n es 0, 1 o 2; R1 y R2 son, cada uno en forma independiente, halogeno.-CN, fenilo, -R, -OR, -perfluoroalquilo C1-6 u -O-perfluoroalquilo C1-6; y cada R es, en forma independiente, H o un grupo alquilo C1-6, y g) hacer reaccionar dicho compuesto de formula (A) con un aldehído de formula R7CHO, o un equivalente del formaldehído adecuado para formar un compuesto de formula (2).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72760605P | 2005-10-17 | 2005-10-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR056695A1 true AR056695A1 (es) | 2007-10-17 |
Family
ID=37681506
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP060104498A AR056695A1 (es) | 2005-10-17 | 2006-10-13 | Tetrahidroquinolinas, su sintesis e intermediarios |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20070088022A1 (es) |
| EP (1) | EP1937684A2 (es) |
| JP (1) | JP2009511633A (es) |
| KR (1) | KR20080057286A (es) |
| CN (1) | CN101331130A (es) |
| AR (1) | AR056695A1 (es) |
| AU (1) | AU2006304480A1 (es) |
| BR (1) | BRPI0617483A2 (es) |
| CA (1) | CA2626215A1 (es) |
| CR (1) | CR9872A (es) |
| EC (1) | ECSP088383A (es) |
| IL (1) | IL190549A0 (es) |
| NO (1) | NO20081621L (es) |
| PA (1) | PA8699501A1 (es) |
| PE (1) | PE20070549A1 (es) |
| RU (1) | RU2008113221A (es) |
| TW (1) | TW200800986A (es) |
| WO (1) | WO2007047671A2 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GT200500317A (es) * | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
| AR054849A1 (es) * | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
| TW200734334A (en) * | 2006-01-13 | 2007-09-16 | Wyeth Corp | Treatment of substance abuse |
| AU2007229491A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | Methods for treating cognitive and other disorders |
| CA2644656A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | Treatment of pain |
| WO2007112073A2 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | Methods for modulating bladder function |
| AU2007231011A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | New therapeutic combinations for the treatment of depression |
| CL2008002777A1 (es) * | 2007-09-21 | 2010-01-22 | Wyeth Corp | Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario. |
| JP5734957B2 (ja) | 2009-04-21 | 2015-06-17 | パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ | ドーパミンレセプターのオクタヒドロベンゾイソキノリンモジュレーター及びその使用 |
| US20130267500A1 (en) | 2010-09-01 | 2013-10-10 | Arena Pharmaceuticals, Inc. | 5-ht2c receptor agonists in the treatment of disorders ameliorated by reduction of norepinephrine level |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19806348A1 (de) * | 1998-02-12 | 1999-08-19 | Schering Ag | 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln |
| TWI312781B (en) * | 2002-04-25 | 2009-08-01 | [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents | |
| WO2004094401A1 (en) * | 2003-04-21 | 2004-11-04 | Eli Lilly And Company | Substituted benzopyrans as selective estrogen receptor-beta agonists |
-
2006
- 2006-10-13 AR ARP060104498A patent/AR056695A1/es unknown
- 2006-10-13 PE PE2006001248A patent/PE20070549A1/es not_active Application Discontinuation
- 2006-10-16 CN CNA2006800472190A patent/CN101331130A/zh active Pending
- 2006-10-16 JP JP2008536737A patent/JP2009511633A/ja active Pending
- 2006-10-16 BR BRPI0617483-3A patent/BRPI0617483A2/pt not_active Application Discontinuation
- 2006-10-16 US US11/581,638 patent/US20070088022A1/en not_active Abandoned
- 2006-10-16 TW TW095138029A patent/TW200800986A/zh unknown
- 2006-10-16 WO PCT/US2006/040546 patent/WO2007047671A2/en active Application Filing
- 2006-10-16 AU AU2006304480A patent/AU2006304480A1/en not_active Abandoned
- 2006-10-16 KR KR1020087009101A patent/KR20080057286A/ko not_active Application Discontinuation
- 2006-10-16 CA CA002626215A patent/CA2626215A1/en not_active Abandoned
- 2006-10-16 RU RU2008113221/04A patent/RU2008113221A/ru not_active Application Discontinuation
- 2006-10-16 EP EP06817057A patent/EP1937684A2/en not_active Withdrawn
- 2006-10-17 PA PA20068699501A patent/PA8699501A1/es unknown
-
2008
- 2008-04-01 IL IL190549A patent/IL190549A0/en unknown
- 2008-04-02 NO NO20081621A patent/NO20081621L/no not_active Application Discontinuation
- 2008-04-08 CR CR9872A patent/CR9872A/es not_active Application Discontinuation
- 2008-04-17 EC EC2008008383A patent/ECSP088383A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2009511633A (ja) | 2009-03-19 |
| PE20070549A1 (es) | 2007-06-15 |
| WO2007047671A2 (en) | 2007-04-26 |
| AU2006304480A1 (en) | 2007-04-26 |
| KR20080057286A (ko) | 2008-06-24 |
| BRPI0617483A2 (pt) | 2011-07-26 |
| TW200800986A (en) | 2008-01-01 |
| CA2626215A1 (en) | 2007-04-26 |
| RU2008113221A (ru) | 2009-11-27 |
| CN101331130A (zh) | 2008-12-24 |
| CR9872A (es) | 2008-08-21 |
| EP1937684A2 (en) | 2008-07-02 |
| NO20081621L (no) | 2008-05-06 |
| IL190549A0 (en) | 2008-11-03 |
| ECSP088383A (es) | 2008-05-30 |
| WO2007047671A3 (en) | 2007-10-04 |
| PA8699501A1 (es) | 2009-06-23 |
| US20070088022A1 (en) | 2007-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR056695A1 (es) | Tetrahidroquinolinas, su sintesis e intermediarios | |
| UY37399A (es) | Proceso químico para la elaboración de determinados derivados de pirimidina | |
| AR054849A1 (es) | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas | |
| AR038971A1 (es) | Derivados de bencimidazol n3 alquilado como inhibidores de mek | |
| DOP2015000014A (es) | Derivados de azaadamantano y metodos de uso de los mismos | |
| AR072839A1 (es) | Derivados adamantil diamida y usos de los mismos | |
| AR051403A1 (es) | Derivados de purina, purinona y deazapurina como inhibidores de la actividad de la protein quinasa; metodos para su preparacion, composiciones farmaceuticas que los contienen y su uso en la elaboracion de un medicamento para el tratamiento de enfermedades mediadas por la protein quinasa a y b. | |
| AR068479A1 (es) | (carboxilalquilenfenil) feniloxamidas, procedimiento para su preparacion y una coomposicion farmaceutica | |
| AR052866A1 (es) | Fenil-metanonas monociclicas sustituidas | |
| ES2531396T3 (es) | Proceso para preparar compuestos de piridinona | |
| AR054557A1 (es) | Tienopirimidinonas, tienopiridazinonas y tienotriazinonas para el tratamiento de obesidad | |
| AR062680A1 (es) | Sintesis de 2-(piridin-2-ilamino) pirido [2,3-d] pirimidin-7-onas | |
| CO6241076A2 (es) | Compuestos de benzamida y aplicaciones de los mismos | |
| AR105965A1 (es) | Derivados de piperidina puenteados | |
| AR049995A1 (es) | Un procedimiento de preparacion de derivados n-piperidino-1,5-difenilpirazol-3-carboxamida | |
| AR055666A1 (es) | Inhibidores inntr | |
| AR060813A1 (es) | Moduladores de mglur5 iii | |
| AR074128A1 (es) | Derivados de 4-[2-(2-fluorofenoximetil)fenil] piperidina, composiciones farmaceuticas que los contienen, metodo de preparacion, compuestos intermediarios de dicho proceso y uso de los mismos para el tratamiento de dolores neuropaticos, mal de alzheimer y otras enfermedades relacionadas con el snc. | |
| AR104331A1 (es) | Derivados de tetrazol | |
| AR061111A1 (es) | Derivados de isoindol utiles para tratar dolor,trastornos gastrointestinales y cancer | |
| PE20231308A1 (es) | Proceso e intermedios para preparar un inhibidor de jak1 | |
| AR057451A1 (es) | Metodos para preparar derivados de acido glutamico | |
| DOP2010000393A (es) | Derivados de dibenzotiazepina y sus usos | |
| AR030332A1 (es) | Compuestos | |
| ATE382038T1 (de) | Für die behandlung von krankheiten wie krebs und atherosclerose geeignete substituierte isochinoline |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |